These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. Centers for Disease Control and Prevention MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696 [TBL] [Abstract][Full Text] [Related]
5. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing. Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of treating multidrug-resistant tuberculosis. Resch SC; Salomon JA; Murray M; Weinstein MC PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403 [TBL] [Abstract][Full Text] [Related]
7. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013. Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179 [TBL] [Abstract][Full Text] [Related]
8. [Management of multidrug-resistant tuberculosis]. Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method]. Şimşek H; Tarhan G; Cesur S Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730 [TBL] [Abstract][Full Text] [Related]
10. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
11. Sources of Multidrug Resistance in Patients With Previous Isoniazid-Resistant Tuberculosis Identified Using Whole Genome Sequencing: A Longitudinal Cohort Study. Srinivasan V; Ha VTN; Vinh DN; Thai PVK; Ha DTM; Lan NH; Hai HT; Walker TM; Thu DDA; Dunstan SJ; Thwaites GE; Ashton PM; Caws M; Thuong NTT Clin Infect Dis; 2020 Dec; 71(10):e532-e539. PubMed ID: 32166306 [TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients. Pawar UM; Kundnani V; Agashe V; Nene A; Nene A Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244 [TBL] [Abstract][Full Text] [Related]
13. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study. Yuen CM; Kurbatova EV; Tupasi T; Caoili JC; Van Der Walt M; Kvasnovsky C; Yagui M; Bayona J; Contreras C; Leimane V; Ershova J; Via LE; Kim H; Akksilp S; Kazennyy BY; Volchenkov GV; Jou R; Kliiman K; Demikhova OV; Vasilyeva IA; Dalton T; Cegielski JP PLoS Med; 2015 Dec; 12(12):e1001932. PubMed ID: 26714320 [TBL] [Abstract][Full Text] [Related]
14. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia. Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641 [TBL] [Abstract][Full Text] [Related]
15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
16. Management of Multidrug-Resistant Tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2018 Jun; 39(3):310-324. PubMed ID: 30071546 [TBL] [Abstract][Full Text] [Related]
17. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases. Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637 [TBL] [Abstract][Full Text] [Related]
18. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850 [TBL] [Abstract][Full Text] [Related]
19. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania. Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572 [TBL] [Abstract][Full Text] [Related]
20. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]